Mifamurtide
- Level
- Commodity
- Parent
- 51201800
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51201812This classification denotes an immunostimulant with the molecular formula C59H108N6O19P.NA.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1LM890Q4FY. European Medicines Agency schedules mifamurtide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25179. The term MIFAMURTIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21, no. 1, 2007, list 57). Most nations schedule mifamurtide under HS 29329990 and SITC 51569. As of Q4 2014, MIFAMURTIDE remains the US FDA Preferred Term for this commodity. Mifamurtide bears US NLM identifiers UMLS ID C0129341 and NCI Concept Code C1394. SMILES: P(=O)(OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC)(OCCNC(=O)C(NC(=O)CCC(NC(=O)C(NC(=O)C(OC1C(NC(=O)C)C(OC(C1O)CO)O)C)C)C(=O)N)C)O.[NA].O.
Same parent
Under 51201800 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51200000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.